PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,000,212 | -27.6% | 3,760,869 | 0.0% | 12.45% | -17.5% |
| Q2 2023 | $53,855,644 | +203.6% | 3,760,869 | +51.4% | 15.09% | +98.5% |
| Q1 2023 | $17,737,716 | -36.4% | 2,484,274 | 0.0% | 7.60% | -35.1% |
| Q4 2022 | $27,873,554 | +1.3% | 2,484,274 | 0.0% | 11.71% | +2.2% |
| Q3 2022 | $27,526,000 | -33.5% | 2,484,274 | -49.3% | 11.46% | +33.4% |
| Q2 2022 | $41,368,000 | +47.0% | 4,901,358 | +137.0% | 8.59% | +12.7% |
| Q1 2022 | $28,143,000 | -30.8% | 2,067,861 | 0.0% | 7.62% | -25.1% |
| Q4 2021 | $40,675,000 | -38.7% | 2,067,861 | 0.0% | 10.18% | -29.5% |
| Q3 2021 | $66,378,000 | -5.2% | 2,067,861 | 0.0% | 14.44% | +15.1% |
| Q2 2021 | $69,997,000 | -9.9% | 2,067,861 | 0.0% | 12.54% | -72.3% |
| Q1 2021 | $77,669,000 | +13.1% | 2,067,861 | 0.0% | 45.24% | +13.3% |
| Q4 2020 | $68,694,000 | -9.4% | 2,067,861 | 0.0% | 39.92% | +10.3% |
| Q3 2020 | $75,828,000 | +11.4% | 2,067,861 | 0.0% | 36.21% | -13.4% |
| Q2 2020 | $68,053,000 | +27.5% | 2,067,861 | 0.0% | 41.82% | -40.0% |
| Q1 2020 | $53,392,000 | -17.1% | 2,067,861 | 0.0% | 69.76% | +76.8% |
| Q4 2019 | $64,393,000 | – | 2,067,861 | – | 39.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |